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Abstract
Background: About 37 genes have been reported to be involved in autosomal recessive retinitis pigmentosa, a
hereditary retinal disease. However, causative genes remain unclear in a lot of cases.
Methods: Two sibs of a Chinese family with ocular disease were diagnosed in Eye and ENT Hospital of Fudan
University. Targeted sequencing performed on proband to screen pathogenic mutations. PCR combined Sanger
sequencing then performed on eight family members including two affected and six unaffected individuals to
determine whether mutations cosegregate with disease.
Results: Two affected members exhibited clinical features that fit the criteria of autosomal recessive retinitis
pigmentosa. Two heterozygous mutations (NM000087, p.Y82X and p.L89fs) in CNGA1 were revealed on proband.
Affected members were compound heterozygotes for the two mutations whereas unaffected members either had
no mutation or were heterozygote carriers for only one of the two mutations. That is, these mutations cosegregate
with autosomal recessive retinitis pigmentosa.
Conclusions: Compound heterozygous mutations (NM000087, p.Y82X and p.L89fs) in exon 6 of CNGA1are
pathogenic mutations in this Chinese family. Of which, p.Y82X is firstly reported in patient with autosomal recessive
retinitis pigmentosa.
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Background
Retinitis pigmentosa (RP, OMIM 268000) refers to a set
of hereditary retinal diseases that feature progressive de-
generation of the rod and cone photoreceptors. The
classic symptom of RP includes early night blindness,
progressive increase of the vision field constriction, pig-
ment accumulation in the outer retina and gradually re-
duced visual acuity. As RP advances, patients will be
eventually complete blindness. Nutritional supplementary
of vitamin A and docosahexaenoic acid (DHA) in early,
could slow progression of disease in many patients [1–4].
RP can be inherited in three patterns-autosomal dom-
inant, autosomal recessive and X-linked which account
for 30 ~ 40 %, 50 ~ 60 and 5 ~ 15 % of the RP patients,
respectively [5–7]. Digenic inheritance and maternal
(mitochondrial) inheritance have also been reported in
few cases [8, 9]. By now, 37 genes have been reported to
responsible for autosomal recessive retinitis pigmentosa
(ARRP) (http://sph.uth.edu/retnet/). Each gene accounts
for 0.6 ~ 20 % of ARRP patients. These genes are mainly
functioned in following pathways: phototransduction
cascade, vitamin A metabolism, structural and cytoskel-
etal and signaling, cell-cell interaction and synaptic
interaction [10]. Although so many genes are identified,
causative genes remain unclear in a lot of cases.
Given the harmful of RP, it’s urgent to diagnose as
soon as possible. However, RP is highly complicated. It’s
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difficult to diagnose only rely on clinical features for
some cases. Molecular diagnosis is an effective supple-
mentary diagnosis method. The traditional way, PCR
combined Sanger sequencing, are time-consuming and
costly if there are a lot of candidate genes need to be ex-
amined. With the advent of next generation sequencing
(NGS) technology, it’s fast to determine the genotype of a
large set of genes in parallel. It’s especially useful as the
price decrease with the progression of this technology.
Target sequencing is a kind of NGS technology which can
rapidly capture the entire protein-coding sequence. Nu-
merous causative mutations were accurately and rapidly
revealed by this method in recent years [11–14].
In this study, a proband of a Chinese family was sub-
jected to target sequencing and 11 variants are identified
as candidate pathogenic mutations. Then, pedigree ana-
lysis showed that only two compound heterozygous mu-
tations (NM000087, p.Y82X and p.L89fs) in exon 6 of
CNGA1 co-segregate with disease. Of which, p.L89fs
was identified in ARRP Japanese patients [15]. P.Y82X is
a novel mutation. We conclude that these mutations are
responsible for ARRP in this family.
Methods
Samples and clinical examination of the RP patients
A Chinese family was recruited from Eye and ENT Hos-
pital of Fudan University. The pedigree of this family ex-
hibits ocular disease with a recessive inheritance pattern
(Fig. 1). A total of eight members including two affected
and six unaffected individuals from this family participated
in this study. Before inclusion, complete ophthalmological
examinations were carried out on the eight members.
These included visual acuity testing (Snellen chart), com-
puterized visual field measurement (Humphrey Visual
Field Analyzer, Carl Zeiss Inc., CA, USA), tests of dark
adaptation (ECLIPSE Dark Adaptometry), color vision
(Ishihara color plate), spectral domain optical coherence
tomography (SPECTRALIS® HRA +OCT, Heidelberg
Engineering Inc., Heidelberg, Germany) and fundus auto-
fluoresence (SPECTRALIS® HRA +OCT, Heidelberg En-
gineering Inc., Heidelberg, Germany). Besides, full field
electroretinogram (LKC Utas E3000 LKC Technologies
Inc., USA) was performed on two affected individuals (II1
and II3, Fig. 1). Medical history of the two affected indi-
viduals was also obtained regarding the following aspects:
subjective degree of vision loss, age at onset, evolution,
medication and other relevant clinical manifestations. In
addition, a total of 400 unrelated volunteers from China
were served as control group. These volunteers show nor-
mal phenotype in visual acuity testing and visual field
measurement and don’t have other obvious serious
diseases. Blood samples were collected from the eight sub-
jects and stored in 4 °C until analysis.
DNA isolation and high-throughput sequencing
Genomic DNA was extracted from peripheral blood
according to manufacturer’s instructions (QIAGEN,
Hilden, Germany). DNA sequencing libraries were then
prepared as followed according to Illumina standard
protocol: genomic DNA was fragmented; Illumina
adapters were ligated to the fragments after ‘A’ ligating
to their 3’ends; Fragments with sample size in 200 to
500base pair were selected and amplified by PCR (each
sample is tagged with a unique index during this proced-
ure). Fragments in the exonic regions of targeted genes
were captured by a specific Hereditary Ophthalmological
Disease GenePanel using biotinylatedoligo-probes (MyGen-
osticsGenCap Enrichment Technologies, MyGenostics, Bal-
timore, MD, USA). The Panel was designed to detect the
coding region of 371 genes which cover almost all of genes
that reported to relate to hereditary ophthalmological dis-
ease (Additional file 1). The capture experiment was con-
ducted according to the manufacturer’s protocol. Briefly,
1μg DNA library was mixed with Buffer BL and GenCap
gene panel probe. The mixture was heated at 95 °C for7min
and 65 °C for 2min. Adding 23 μl of the 65 °C prewarmed
Fig. 1 Pedigree of the Chinese family. Circles and squares represent females and males, respectively. Two filled squares represent two patients
with ARRP in this family. Proband is indicated by arrow. Subjects who participate in DNA analysis are labeled with numbers
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Buffer HY (MyGenostics) to mixture, then hybridizate at 65
°C for 22 h. After adding 64 μl 2X binding buffer and 80 μl
MyOnebeads(Life Technology), the hybrid mixture was
transferred to the tube. The mixture was rotated and the
beads were washed. The bound DNA was then eluted
followed by amplification activated at 98 °C for 30 s (1
cycle), 98 °C for 25 s, 65 °C for 30 s, 72 °C for 30 s (15 cy-
cles), 72 °C for 5 min (1 cycle). The PCR products were
purified and then sequenced by IlluminaHiSeqTm 2000 se-
quencer, generating 2 × 100 bp reads. Base was called using
the Off-Line Base Caller v1.9.
Bioinformatics analysis
Raw reads were firstly filtered out low quality reads and
adaptor sequences using Trimmomatic [16]. The PCR
duplicates were removed using the Picard software
(http://broadinstitute.github.io/picard/). Then, clean
reads were align to the human reference genome (hg19)
using BWA [17]. Sequence variations including single
nucleotide polymorphisms (SNPs) and insertions or de-
letions (InDels) were identified using the GATK program
(https://www.broadinstitute.org/gatk/). A variant locus
with at least five reads support and minor allele fre-
quency >0.3 was kept in variant analysis. The identified
SNPs and InDels were annotated using the ANNOVAR
(http://annovar.openbioinformatics.org/en/latest/). IGV
was used to view the short read alignment and validate
the candidate SNPs and InDels (http://www.broadinsti-
tute.org/igv/). The variants are further filtered to identify
pathogenic mutations. A variant is determined as patho-
genic mutation mainly based on the following three
principals: 1) It predicted to alter the sequence of
encoded protein, 2) it occurs in different frequency be-
tween case group and normal group, 3) it co-segregate
with disease in family carrying it. Specifically, novel vari-
ants with synonymous effect or minor allele frequency
(MAF) >0.01 in 1000 genome variants database or
ESP6500 database are discarded. And for known vari-
ants, functional effect is not taken into consideration
since variant with synonymous effect is yet reported.
Only those variants with MAF >0.05 in 1000 genome
variants database or ESP6500 database are discarded.
Mutation analysis of CNGA1
Two mutations in exon 6 of CNGA1 (NM_000087,
c.265delC and c.246C > A) were determined by PCR
combined with Sanger DNA sequencing in 8 family
members. In brief, genomic DNA was extracted and
amplified by PCR on standard condition. The primer se-
quences and precise PCR conditions are available from
the authors on request. Undirectional sequencing was
carried out using the forward primers. And if this failed,
reverse primers were used to sequencing. Sanger se-
quencing was performed using the ABI PRISMBig Dye
Terminator cycle sequencing ready reaction kit on a
3100 ABI DNA sequencer (Thermo-Fisher).
Results
Clinical assessments
Clinical characteristics of the two affected sibs in this
family are listed in Table 1. Both affected individuals suf-
fer from night blindness in early childhood, progressive
loss of visual fields and decreased visual acuity with age.
All of the features fit the diagnostic criteria of RP.
Table 1 Clinical characteristics of two affected sibs in the family
Patient II.3 II.1
Onset (years)
Night blindness 5 9
Visual field defect 16 24
Decreased visual acuity 20 31
Ophthalmological
examination
Visual acuity RE CF/10 RE 20/60
LE CF/20 LE 20/80
Slit lamp Mild cataract Normal
Visual field RE/LE: not detectable RE/LE: nasal and temporal defects
Fundus RE/LE: paravascular bone spicule pigmentation, RPE
atrophy, pale disc, arteriolar constriction
RE/LE: paravascular bone spicule pigmentation, RPE
atrophy, pale disc, arteriolar constriction
Optical coherence
tomography
RE/LE: extensive ellipsoid band loss, RPE thinning RE/LE: peripheral ellipsoid band loss, peripheral RPE
thinning
Fundus autofluorescence RE/LE: extensive hypo-fluorescence in the posterior pole RE/LE: hyper-fluorescent ring in the macula
Electroretinogram RE/LE: extinguished RE/LE: extinguished
RE right eye, LE left eye, CF counting finger, RPE retinal pigment epithelium
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Proband eventually completely lost of his sight when he
was ~50. Furthermore, fundus examination of proband
shows the typical RP appearance including paravascular
bone spicule pigmentation, retinal pigmented epithelium
atrophy, pale disc, and arteriolar constriction (Fig. 2).
Optical coherence tomography (OCT) showed both eyes
of proband had a similar change as shown in Fig. 2. That
is, severe ellipsoid band loss in outer retina, obvious loss
of retinal nerve fiber, thin retinal pigment epithelium
(RPE) and choroid thickness. Meanwhile, both eyes of
proband had completely loss of retinal nerve fiber layer
(RNFL) without enlargement of cup/disc ratio. The six
unaffected individuals showed normal phenotype in all
the ophthalmological examinations except that III1 and
III2 were suffering from myopia.
Pathogenic mutation detection
Targeted sequencing is performed on Proband (II3) using a
specific Hereditary Ophthalmological Disease GenePanel.
This gene panel includes almost all genes that have been
reported to relate to ophthalmological diseases. In total,
5,160, 906 *2 pair-end reads are generated. ~99 % of tar-
geted regions are sequenced, reaching an average depth of
~297 fold which allowed to accurately identification of a
SNP. Specifically, the average read depth of ARRP genes is
~311 fold, rang from 56 to 948. A total of 502 variants,
including 494 SNVs and eight Indels are identified in target
regions. According to the functional effects, the vari-
ants are categorized as synonymous, non-synonymous,
splice-site, stop-gain, frameshift, non-frameshift and
unknown group.
Eleven variants are identified as candidate pathogenic
mutations after filtering step as described in methods.
Of which, three variants (ATXN1:NM_000332:p.E357K,
TCF4:NM_001243226:c.1793-5G > A and KRT3:NM_057
088:c.1189-5T > C) are known pathogenic variants of
dominant retinitis pigmentosa. Two variants (CNGA1:
NM_000087:Y82X and CNGA1: NM_000087:L89fs) are
involved in ARRP. And the rest variants (USH2-
A:NM_206933:c.11549-5T > -, COL4A3:NM_000091:p.I156
7S, TLR4:NM_003266:p.E434K, INPP5E:NM_019892:p.Q
633E, HMCN1:NM_031935:p.V170I and KRT6B:NM_005
555:p.V454I) are involved in other type of ophthalmological
diseases. To determine which variants are the pathogenic
mutations, co-segregation analysis is performed on 8 mem-
bers of this family (II1, II2, II3, II4, III1, III2, III3 and IV1,
Fig. 1). Result shows that only the two compound heterozy-
gous mutations in CNGA1co-segregate with this disease
(Additional files 2 and 3). Both of the two affected individ-
uals (II1 and II3) carry two heterozygous variants. Two un-
affected individuals (III1 and III2) only carry one of the two
heterozygous variants. And the other four unaffected indi-
viduals (II2, II4, III3 and IV1) are in wild type for the two
loci (Fig. 3). Furthermore, the frequency of the two muta-
tions is 0.0074 and 0 in the control group consists of 400
unrelated healthy individuals, respectively (Table 2). Based
on mutation analysis and the clinical assessment, we
conclude that the compound heterozygous mutations are
the pathogenic variants of ARRP in this family.
CNGA1 was reported as a causative gene of ARRP
[18]. The first mutation (CNGA1: NM_000087:L89fs)
leads a frame shift from residue 89 of the protein, which
was reported in ARRP Japanese patient. And the second
one (CNGA1: NM_000087:Y82X), a novel mutation,
leads to generate a premature termination codon at
residue 82. Both of the two mutations occur early in the
reading frame that clearly would change the function of
the protein.
Fig. 2 Fundus and OCT images. Fundus and OCT photographs from proband show typical changes of RP. a: right eye b: left eye
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Discussion
CNGA1 encodes a protein-a subunit of the rod cGMP-
gated channel, which involved in the phototransduction
pathway [19]. Functional protein of CNGA1 consists of
six putative transmembrane domains and a pore region.
Several mutations in CNGA1 have been revealed to be
pathogenic mutations for ARRP by now [15, 18, 20–23].
In which, mutations that lead to deletion of transmem-
brane domains were reported to be totally nonfunc-
tional. Protein which contains mutations that leads to
deletion of C-terminal 32 residues can’t locate to cell
membrane although the normal channel activity still
maintained. The two mutations (c.265delC and c.246C >
A) that we identified in this study occur early in the
reading frame which lead to lost most of coding region
including all transmembrane domains. It is speculated
that no functional CNGA1 protein was generated in
affected individuals of this family.
So far, several studies reported RP patients with
CNGA1 mutations. All patients including the two sibs
we reported here generally showed typical characteristics
of RP [15, 20, 24, 25]. For example, they noticed night
blindness in early childhood, gradually lost visual field
and decreased in visual acuity. Most of them had a
severely constrained peripheral visual field. Only one
patient showed ring scotoma with a preserved peripheral
visual field [15]. In our study, II.1 had a nasal and tem-
poral visual field and II.3 lost all of visual field. Notice-
ably, II.3 was observed to suffer mild cataract under slit-
lamp testing. This was not reported in other patients
with CNGA1 mutation. The fundus images of all the
patients showed pale optic discs, attenuation of retinal
vessels, bone spicule pigmentation and retinal pigment
epithelium atrophy. Some of the patients had normal
macular region and some of them were identified with
retinal degeneration in macular regions. In our study,
II.1 showed an abnormal high density ring in macula in
the image of fundus autofluorescence which was also
observed in a patient from China [24]. Both of the two
affected sibs showed extinguished ERG signal which was
common in other studies. When scanned by spectral
domain optical coherence tomography (SD-OCT), the
proband showed unusual retinal changes. That is, both
eyes had completely loss of retinal nerve fiber layer
(RNFL) without enlargement of cup/disc ratio. This
feature was unusual because many RP patients had
Fig. 3 CNGA1 sequence variation analysis. CNGA1 sequence variation pattern are clarified into three types: wild type, no mutation in the
two loci; carrier, only one of the two loci in mutant status; affected: two loci were in mutant status. Individuals belong to each type are
presented in parenthesis
Table 2 CGNA1 mutations detected in proband
Gene symbol Position Transcript ID Exon NO. DNA change Protein change Hom/Het Frequency
CNGA1 chr4 47951884-47951885 NM_000087 exon 6 c.265delC p.L89fs het 0.0074
CNGA1 chr4 47951903 NM_000087 exon 6 c.246C > A p.Y82X het 0
Hom homozygous, Het heterozygous, Frequency: mutation frequency in control group of 400 healthy individuals
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thicker RNFL even in the late stage of the disease [26].
We assume that this type of genetic mutation may lead
to severer optic nerve atrophy than other genotype.
About 2.5 % patients with ARRP are caused by muta-
tions in CNGA1 in western population [25]. Only few
studies reported the genetic causes of ARRP in Chinese
population [24, 27]. Here we reports mutations in
CNGA1 responsible for ARRP in Chinese population,
which expand our knowledge about APPR in Chinese
population.
Conclusion
In this study, we descried a Chinese family in which two
sibs suffer from severe ocular disease. Proband even
completely losses his sight. Disease was transmmitted
via autosomal recessive pattern in this family. Clinical
measurements show that their symptom fit the criteria
of ARRP. By screening 371 genes which have been re-
ported to contribute to hereditary eye disease, two com-
pound heterozygous mutations in the exon 6 of CNGA1
(c.265delC and c.246C > A) were revealed. Furthermore,
pedigree analysis was shown that the heterozygous mu-
tations co-segregate with disease. Together, the results
demonstrate that the compound heterozygous mutations
are the pathogenic mutations of ARRP in this family. Of
the two mutations, c.246C > A is a novel mutation.
Additional files
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Ophthalmological Disease GenePanel. (XLSX 12 kb)
Additional file 2: The status of nine mutations in eight family members
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Additional file 3: Sequencing image of nine mutations in eight family
members which are ruled out from pathogenic mutations. (PDF 159 kb)
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